Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · April 24, 2023

Triple-Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Gel for Moderate to Severe Acne in Children and Adolescents

Pediatric Dermatology


Additional Info

Pediatric Dermatology
Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study
Pediatr Dermatol 2023 Mar 22;[EPub Ahead of Print], LF Eichenfield, L Stein Gold, LH Kircik, WP Werschler, K Beer, ZD Draelos, EA Tanghetti, KA Papp, H Baldwin, E Lain, N Sadick, MJ Gooderham, A Konda

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading